Forward- And Inverse-Planned Intensity-Modulated Radiotherapy in the CHHiP Trial: A Comparison of Dosimetry and Normal Tissue Toxicity

Clinical Oncology - United Kingdom
doi 10.1016/j.clon.2019.05.002

Related search